Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-069759
Filing Date
2014-11-18
Accepted
2014-11-18 18:29:45
Documents
1
Period of Report
2014-11-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17036
  Complete submission text file 0001209191-14-069759.txt   18436
Mailing Address C/O NEWLINK GENETICS CORP. 2503 SOUTH LOOP DR., SUITE 5100 AMES IA 50010
Business Address
Edick Paul R (Reporting) CIK: 0001531178 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35599 | Film No.: 141233146

Mailing Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606
Business Address 200 SOUTH WACKER DRIVE SUITE 2550 CHICAGO IL 60606 312-219-7000
Durata Therapeutics, Inc. (Issuer) CIK: 0001544116 (see all company filings)

EIN.: 871247903 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations